DELFINI LISA (Chief Financial Officer) sold 2.0% of their position (562.00 shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/15/2023ACC: 0001209191-23-029399
Officer· Chief Financial Officer
Since Aug 2021
-562.00
Net shares
Net seller
$1.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.29K acquired · 2.85K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.29K
Price / share
$0.51
Trade value
$1.17K
% of position
8.7%
5/11/2023
26.19K→28.48K
Common Stock
Direct
Shares
−562.00
Price / share
$2.89
Trade value
$1.62K
% of position
2.0%
5/11/2023
28.48K→27.92K
Total
Net shares
+1.73K
Net value
-$453.48
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2023 | M · Option Exercise | +2.29K | $0.51 | $1.17K | 8.7% | 26.19K | 28.48K |
| Common Stock Direct | 5/11/2023 | S · Sale | −562.00 | $2.89 | $1.62K | 2.0% | 28.48K | 27.92K |
| Total | +1.73K | -$453.48 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
2.29K shares
Shares
−2.29K
Strike price
0.511
Held after
75.63K
Exercisable
—
5/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2.29K shares | 5/11/2023 | M · Option Exercise | −2.29K | 0.511 | — | 75.63K |